Delivery Order SPE2DB20D2002-SPE2DB23FL59Q
Award Date
8/9/23
Potential Completion Date
8/10/23
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.55 firm fixed-price contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE medication, with a completion date of June 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $27,942.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, is for the delivery of HAVRIX 1,440 unit/mL syringes. The award has a firm fixed price pricing type and an ultimate completion date of May 19, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that is a critical...
This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,925.10 firm fixed-price contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products, with a completion date of December 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,769.15 firm fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, which are likely vaccines or other medical supplies. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The $1,833.70 fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine, with a completion date of March 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,423.56 Firm Fixed Price Delivery Order is for the supply of 4,567,893,721 units of the HAVRIX 1,440 unit/mL syringe medication. The contract has an ultimate completion date of April 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,732.50 firm fixed-price delivery order is for the supply of HAVRIX 720 UNIT/0.5 ML syringes. The contract has an ultimate completion date of October 2, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,567.92 firm fixed price delivery order to provide 4,563,580,840 units of the HAVRIX 720 0.5 ML syringe. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,800.70 firm fixed-price delivery order is for the supply of HAVRIX 1,440 unit/mL syringes. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award, valued at $30,871.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE/ML, a medical product, with a period of performance through March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...